Back to Search Start Over

Visulization of peroxynitrite variation for accurate diagnosis and assessing treatment response of hepatic fibrosis using a Golgi-targetable ratiometric fluorescent probe.

Authors :
Zhang T
Li Z
Qin M
Zhang J
Sun Y
Liu C
Source :
Journal of photochemistry and photobiology. B, Biology [J Photochem Photobiol B] 2024 Aug; Vol. 257, pp. 112950. Date of Electronic Publication: 2024 Jun 04.
Publication Year :
2024

Abstract

Hepatic fibrosis (HF) is caused by persistent inflammation, which is closely associated with hepatic oxidative stress. Peroxynitrite (ONOO <superscript>-</superscript> ) is significantly elevated in HF, which would be regarded as a potential biomarker for the diagnosis of HF. Research has shown that ONOO <superscript>-</superscript> in the Golgi apparatus can be overproduced in HF, and it can induce hepatocyte injury by triggering Golgi oxidative stress. Meanwhile, the ONOO <superscript>-</superscript> inhibitors could effectively relieve HF by inhibiting Golgi ONOO <superscript>-</superscript> , but as yet, no Golgi-targetable fluorescent probe available for diagnosis and assessing treatment response of HF through sensing Golgi ONOO <superscript>-</superscript> . To this end, we reported a ratiometric fluorescent probe, Golgi-PER, for diagnosis and assessing treatment response of HF through monitoring the Golgi ONOO <superscript>-</superscript> . Golgi-PER displayed satisfactory sensitivity, low detection limit, and exceptional selectivity to ONOO <superscript>-</superscript> . Combined with excellent biocompatibility and good Golgi-targeting ability, Golgi-PER was further used for ratiometric monitoring the Golgi ONOO <superscript>-</superscript> fluctuations and screening of ONOO <superscript>-</superscript> inhibitors from polyphenols in living cells. Meanwhile, using Golgi-PER as a probe, the overexpression of Golgi ONOO <superscript>-</superscript> in HF and the treatment response of HF to the screened rosmarinic acid were precisely visualized for the first time. Furthermore, the screened RosA has a remarkable therapeutic effect on HF, which may be a new strategy for HF treatment. These results demonstrated the practicability of Golgi-PER for monitoring the occurrence, development, and personalized treatment response of HF.<br />Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2024 Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1873-2682
Volume :
257
Database :
MEDLINE
Journal :
Journal of photochemistry and photobiology. B, Biology
Publication Type :
Academic Journal
Accession number :
38851042
Full Text :
https://doi.org/10.1016/j.jphotobiol.2024.112950